治疗耐药抑郁症的遗传学和神经生物学-一篇评论
Olga Płaza1, Piotr Gałecki2, Katarzyna Bliźniewska-Kowalska2
1Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, 05-802 Pruszków, Poland.
International journal of molecular sciences
|November 27, 2025
概括
耐治疗抑郁症 (TRD) 涉及复杂的遗传和神经生物学因素. 了解这些基础对于开发有效的治疗策略对于这种具有挑战性的疾病至关重要.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 精神病学是一个精神病学.
背景情况:
- 耐治疗性抑郁症 (TRD) 影响20-30%的大型抑郁症患者.
- TRD带来了重大的个人和社会经济负担.
- 目前对TRD病理生理学的理解仍然不完整.
研究的目的:
- 综合当前关于TRD遗传,表观遗传和神经生物学因素的知识.
- 为了提高对TRD病理生理学的理解.
- 为TRD的未来治疗策略提供信息.
主要方法:
- 系统的文献搜索关于TRD的研究.
- 专注于遗传倾向,表观遗传修饰和神经生物学变化.
- 包括神经成像,炎症,神经可塑性和神经生成研究.
主要成果:
- TRD涉及影响神经传递和神经可塑性的基因多态,但研究结果缺乏一致性.
- 全基因组关联研究表明多基因影响,受样本大小和定义异质性限制.
- 异常的表观遗传修饰 (DNA甲基化,基因质修饰,非编码RNA) 和改变的大脑连接 (默认模式网络) 都与TRD有关.
- 神经成像显示了TRD的独特模式,表明它是一种抑郁症亚型.
结论:
- TRD是一种多因素的疾病,受遗传和神经生物学因素的影响.
- 需要标准化的定义,更大的队列和纵向研究.
- 进一步的研究可以推进TRD的治疗策略.
相关概念视频
Human Genetics
1.4K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
Antidepressant Drugs: MAOIs and Other Agents
776
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
776
Depression: Overview
753
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
753
Depressive Disorders: Etiology
419
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
419
Electroconvulsive Therapy
820
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
820
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


